• Nem Talált Eredményt

mice The effects of CRF and urocortins on the preference for social noveltyof Behavioural Brain Research

N/A
N/A
Protected

Academic year: 2022

Ossza meg "mice The effects of CRF and urocortins on the preference for social noveltyof Behavioural Brain Research"

Copied!
9
0
0

Teljes szövegt

(1)

ContentslistsavailableatScienceDirect

Behavioural Brain Research

j o ur na l h o me p a g e :w w w . e l s e v i e r . c o m / l o c a t e / b b r

Research report

The effects of CRF and urocortins on the preference for social novelty of mice

Zsolt Bagosi

, András Czébely-Lénárt, Gergely Karasz, Krisztina Csabafi, Miklós Jászberényi, Gyula Telegdy

DepartmentofPathophysiology,FacultyofMedicine,UniversityofSzeged,Hungary

h i g h l i g h t s

•MaleandfemaleCFLPmicewereinvestigatedinaCrawleysocialinteractiontest.

•CRFandUCN1decreasedthepreferenceforsocialnoveltyofmalemice.

•CRF1receptormediatestheeffectsofCRFandUCN1onmale-femaleinteraction.

•UCN2andUCN3didnotinfluencethepreferenceforsocialnoveltyofmalemice.

•CRF2receptordoesnotparticipatetomale-femaleinteraction.

a r t i c l e i n f o

Articlehistory:

Received7December2016

Receivedinrevisedform1February2017 Accepted6February2017

Availableonline9February2017

Keywords:

CRF Urocortins Socialnovelty Mice

a b s t r a c t

Theaimofthepresentstudywastodeterminetheroleofcorticotropin-releasingfactor(CRF),theuro- cortins(UCN1,UCN2andUCN3)andtheirreceptors(CRF1andCRF2)inthepreferenceforsocialnovelty ofmice.MaleCFLPmicewereadministeredintracerebroventricularly(ICV)withCRF,UCN1,UCN2 orUCN3and/orantalarminorastressin2B,selectiveantagonistsofCRF1receptorandCRF2receptor, respectively.ThemicewereinvestigatedinaCrawleysocialinteractiontestarenaconsistingofthree chambers:anunknownfemalewassetinthefirstchamberandaknownfemale,withwhichthemale wasfamiliarizedpreviouslyfor24h,wassetinthethirdchamber.Firstthetestedmalewashabituated withthemiddlechamberfor5minandthenallowedtoexploretheremainingchambersfor5min,during whichthenumberofentriesandthetimeofinteractionweremeasured.CRFdecreasedsignificantlythe numberofentriesandthetimeofinteractionwiththeunknownfemale,butnottheknownfemale.UCN 1decreasedsignificantlythenumberofentriesintothechamberoftheunknownfemale,butnotthe knownfemale,withoutchangingthetimeofinteraction.Alldecreasingeffectswerereversedbyanta- larmin,butnotastressin2B.UCN2andUCN3didn’tinfluencesignificantlyanyoftheparameters.The presentstudysuggeststhatCRFandUCN1decreasethepreferenceforsocialnoveltybyactivatingCRF1

receptor,whileUCN2andUCN3,activatingselectivelyCRF2receptor,donotparticipatetomale-female interaction.

©2017ElsevierB.V.Allrightsreserved.

1. Introduction

Corticotropin-releasingfactor(CRF)isa hypothalamicneuro- hormone and also an extrahypothalamic neurotransmitter that regulatestheendocrine,autonomicandbehavioral responsesto stress[1].DuringstressCRF,alongwiththesynergisticarginine-

Correspondingauthorat:DepartmentofPathophysiology,UniversityofSzeged, 6725,Szeged,Semmelweisstr.1,Hungary.

E-mailaddress:bagosi.zsolt@med.u-szeged.hu(Z.Bagosi).

vasopressin(AVP),isreleasedfromtheparaventricularnucleusof thehypothalamus(PVN)and,gettingintothecirculationthrough themedianeminence,stimulatesthereleaseoftheadrenocorti- cotropichormone(ACTH)intheanteriorpituitary[1].ACTH,inturn stimulatesthesynthesisofglucocorticoidsintheadrenalcortex resultinginelevationoftheconcentrationoftheplasmaglucocorti- coids[2].Theelevationoftheplasmaglucocorticoidconcentration not only reflects the activation of the hypothalamic-pituitary- adrenal (HPA)axis,but also exerts negativefeedback effect on thehypothalamicCRFandthepituitaryACTHrelease,inhibiting theHPAaxis[3].ICVinjectionofCRFand UCNImaystimulate http://dx.doi.org/10.1016/j.bbr.2017.02.009

0166-4328/©2017ElsevierB.V.Allrightsreserved.

(2)

ACTHsecretionintheanteriorpituitarythatpeaksin15minand maydecreasetheactivesocialinteraction.ACTH,inturnstimulates thesynthesisofglucocorticoidsintheadrenalcortexresultingin elevationoftheconcentrationoftheplasmaglucocorticoids[2].

Theelevationoftheplasmaglucocorticoidconcentrationnotonly reflectstheactivationofthehypothalamic-pituitary-adrenal(HPA) axis,butalsoexertsnegativefeedbackeffectonthehypothalamic CRFandthepituitaryACTHrelease,inhibitingtheHPAaxis.

SinceCRFwasfirstlyisolated[1],agrowingfamilyofCRF-like peptideshavebeendiscovered.Todaythemammalianmembers ofthisfamilyincludefourligands:CRF,urocortin1(UCN1)[4], urocortin2 (UCN2),alsoknown asstresscopin-relatedpeptide (SRP)[5],andurocortin3(UCN3),alsoknownasstresscopin(SCP) [6],two receptors(CRF1 and CRF2)[7]and onebindingprotein (CRF-BP)[8].Thenameurocortinderivesfromthefishhomologue urotensin(63%sequenceidentity)andthemammaliananalogue corticotropin(45%sequenceidentity)[9],astheurocortinsshare commonaminoacidicelements(45–33%),buthavedifferentphar- macologicalpropertiescomparedtoCRF.CRFbindspreferentially toCRF1receptor,whileUCN1attachesequipotentlytobothCRF receptors(CRF1andCRF2),andUCN2andUCN3bindselectively toCRF2receptor[10].ThesereceptorsbelongtotheclassBsubtype ofGprotein-coupledreceptors(GPCRs)and,likeallGPCRs,con- sistofanamino-terminalextracellularregion,acarboxyl-terminal intracellulartailandseven,transmembranesegments,connected byalternatingintracellularandextracellularloops[11].Thereis nearly70%identitybetweenCRF1andCRF2receptorsattheamino acidlevelwiththetransmembraneandintracellulardomainsofthe CRFreceptorspresentingthehighesthomology(over80%identity) [11].Inaddition,CRFandUCN1canbefoundattachedtoCRF-BP [10],whichwasfoundinthebrainandthepituitaryandisthought toinhibittheactionsofCRFandUCN1[8].

Asregardstheanatomicaldistributionoftheligands,theyare represented both in the brain and the peripheral tissues [12].

CRFissynthesizedmainlyinthehypothalamus(PVN),thecentral nucleusoftheamygdalaandthehindbrainregionsintheCNS,and expressedinthegut,skin,andadrenalglandintheperiphery.UCN 1expressionhasbeendescribedpredominantly intheEdinger- Westphalnucleusinthebrainandexpressedinthegastrointestinal tract,testis, cardiac myocytes, thymus, skin, and spleen in the periphery.UCN2expressionhasbeendetectedinthehypotha- lamus(e.g.arcuatenucleus),thebrainstemandthespinalcordin thecentralnervoussystem(CNS),andintheheart,thebloodcells andtheadrenalglandintheperiphery.UCN3expressionhasbeen observedintheamygdala(e.g.medialnucleus)intheCNS,andin thegastrointestinaltractandthepancreasintheperiphery[13].

Asregardstheanatomical localizationofthereceptors,CRF1

receptorisrepresentedmoreanundantlyintheCNS,whereasCRF2 receptorisdistributedpredominantlyintheperiphery[12].Inthe CNS,CRF1receptorisexpressedinthecerebralcortex,thecerebel- lumandtheanteriorpituitary,butalsofoundintheamygdala,the striatumandthehypothalamus[14].CRF2receptorislimitedcen- trallytosubcorticalregions:theamygdala,thehippocampusand thehypothalamusandscatteredallovertheperiphery:theheart, thegastro-intestinaltract,thelung,theskeletalmusclesandthe vessels[14].

Besidestheirprincipalroleinthemodulationofstressresponses [15–18],regulationoffoodintakeandsatiety[19],gastrointesti- nalmotility[20],vasodilationandcardioprotection[21],CRFand theCRF-relatedpeptideshavebeenimplicatedinsocialinteraction [22–24],althoughtheirintimaterolewasnotinvestigatedthor- oughly[25,26].Hence,theaimofourstudywastodeterminethe roleofCRF,theurocortins(UCN1,UCN2andUCN3)andtheir receptors(CRF1 andCRF2)inthepreferenceforsocialnoveltyof mice.

2. Materialsandmethods 2.1. Animals

MaleandfemaleCFLPmiceweighing24–30gwereused.The totalnumberofmicewas504,ofwhich168malesand336females (dividedin168partnerfemalesand168strangerfemales).CFLP micewereusedbecauseweintendedtotestanoutbredstrainof mice,ratherthananinbredstrain,suchasC57/BL6mice,which, accordingtopreviousstudies,failtoexhibitpreferenceforsocial noveltyinthethree-chamberapparatus[27].Femalemicewere usedaspartnersorstrangersinsteadofthemalemice,becausewe aimedtoinvestigatethepreferenceforsocialnoveltyfollowingpair bondformation(male-femaleinteraction),andnotsocialaffiliation (male–maleinteraction).Four-fivemaleswerehousedtogetherin theirhomecagesandseparatedfromthestrangerfemales,butthen kepttogetherwiththepartnerfemalesfor24hbeforetheexperi- mentsstarted.Duringtheexperimentstheanimalswerekeptand handledinaccordancewiththeinstructionsoftheUniversityof SzegedEthicalComitteefortheProtectionofAnimalsinResearch, atconstantroomtemperature(23C)onastandardillumination schedule,with12-hlightand12-hdarkperiods(lightsonfrom6:00 a.m.).Commercialfoodandtapwaterwereavailableadlibitum.All experimentswereperformedinaccordancewiththeARRIVEguide- linesandtheU.K.Animals(ScientificProcedures)Act,1986and associatedguidelines,EUDirective2010/63/EUforanimalexperi- ments.

2.2. Surgery

The mice were implanted with a stainless steel Luer can- nula of 10mm lengthand 0.4mm diameteraimed atthe right lateralcerebralventricleunderanesthesiawith60mg/kgEuthana- sol (CEVA-Phylaxia,Hungary).The stereotaxiccoordinates were 0.5mmposteriorand0.5mmlateraltothebregma,and3mmdeep fromtheduralsurface,adaptedfromtheatlasdescribingthemouse braininstereotaxiccoordinates[28].Cannulasweresecuredtothe skullwithdentalcementandacrylate.Thepolyethylenetubeofthe injectorhaving0.8mmoutsidediameterand0.4mminsidediam- eterwasfittedcloselyintothecannulawithasharppointingtip projectingbeyondthecannula.Themicewereallowedfor5days torecoverafterthesurgeryandthepermeabilityofthecanullawas testedwithmethylene-blueaftertheexperiments.Thehitandmiss ratiowas168–143,whichmeans85%forrightpositioningofthe cannula.

2.3. Treatment

Fourexperimentswereperformedwithfourdifferentgroups.In experimentI,thefirstgroupwastreatedwith2␮lsalinesolution, thesecondonewith5␮g/2␮lCRF,thethirdonewith0.1␮g/2␮l of the selective CRF1 receptor antagonist antalarmin and the fourthonewith1␮g/2␮loftheselectiveCRF2receptorantagonist astressin2B,30minbeforethesocialinteractiontest.Inexperi- mentII,thefirstgroupwastreatedwith2␮lsaline,theremaining groups weretreated with5␮g/2␮l CRF,30minbeforethetest and pretreatedin orderwith2␮lsaline, 0.1␮g/2␮lantalarmin or1␮g/2␮lastressin2B,60minbeforethetest.InexperimentIII, thefirstgroupwastreatedwith2␮lsaline,thesecond,thethird andthefourthoneswith5␮g/2␮lUCN1,5␮g/2␮lUCN2and 5␮g/2␮lUCN3,respectively,30minbeforethetest.Inexperiment IV,thefirstgroupwastreatedwith2␮lsaline,theremaininggroups weretreatedwith5␮g/2␮lUCN1,30minbeforethetestandpre- treatedinorderwith2␮lsaline,0.1␮g/2␮lantalarminor1␮g/2␮l astressin2B60minbeforethetest.Thesaline(0.9%NaCl)solution wasprovidedbyBiogalLtd.,Hungary,CRF,UCN1,UCN2andUCN

(3)

3werepurchasedfromBachemLtd.,Switzerland,andantalarmin andastressin2BwerepurchasedfromSigmaAldrichInc.,USA.The ICVinfusionofthesubstanceswasperformedwithahand-held microinjector(HormuthLtd.,Germany)andthemice,beingprevi- ouslyhandleddailytominimizetheeffectsofnonspecificstress, werealsohand-heldduringinfusion.

2.4. Socialinteractiontest

ThirtyminutesaftertheICVinjectionofthepeptidesmicewere investigatedinasocialinteractiontestarenadescribedoriginallyby Crawleyandcolleaguesandusedtotestthesociabilityandthepref- erenceforsocialnoveltyofmice.[29].Inthepresentexperiments weusedamodifiedversionofthistestthatwasmeanttoinvesti- gatethepreferenceforsocialnoveltyfollowingpairbondformation (male-femaleinteraction), but not social affiliation (male–male interaction).Theprincipleofthetestisbasedontheassessment thatawildtypemousewouldvisitandspendmoretimewiththe strangerfemaleoverthepartnerfemale,indicativeforanintact socialmemoryandanaturalpreferenceforsocialnovelty.

Theapparatusisarectangular,three-chamberboxmadefrom clearPlexiglass.Eachchamberisof19×45×25cm,withanopen middlesection,whichallowsfreeaccesstoeachchamber.Theright andleftchamberscouldbeisolatedfromthemiddleonebyusing twodividingPlexiglasswalls.Twoidentical,wirecup-likecellsof 10×17cmwithremovablelidsthatlargeenoughtoholdasin- glemousewereplacedverticallyinsidetheapparatus,oneineach sidechamber.Eachcelliscomprisedofmetalwirestoallowfor airexchangebetweentheinteriorandexteriorofthecylinderbut smallenoughtopreventdirectphysicalinteractionsbetweenan animalontheinsidewithoneontheoutside.

Inthepresentexperimentsanunknownfemalemouse(stranger female)wassetinthefirstchamberandaknownfemalemouse (partner female), withwhich themale was familiarizedprevi- ouslyfor24h,wassetinthethirdchamber.Firstthetestedmale mousewashabituatedwiththemiddlechamberfor5minandthen allowedtoexploretheremainingchambersfor5min,duringwhich thenumberofentriesandthetimeofinteractionweremeasured.

Thetestedmalemousewashabituatedforthemiddlecompart- mentfor5min,butnottheothercompartments.Thepartnerand thestrangerfemalemiceweretransferredintheirhomecagesinto thebehavioralroom30minbeforethefirsttrial,buttheywerenot habituatedpreviouslytothecompartments.Thepartnerandthe strangermiceweresystematicallyalternatedbetweentheleftor rightcompartmentacrossthetrialstopreventsidepreference.All trialswereperformedbetween9:00a.m.and13:00p.m.General roomlightingwas650lx.Thepersonwhomadetheobservation wasatleast2mawayfromtheapparatus.Aftereachtrial,allcham- berswerecleanedwith70%ethanolandthenwithClidox1:5:1to preventolfactorycuebiasandtoensureproperdisinfection[30].

2.5. Statisticalanalysis

Statisticalanalysis of theresultswas performedby analysis ofvariance(ANOVA, GraphPadPrismSoftware).Thedifferences betweengroups were tested by two-way ANOVA, followed by Tukey post-hoc comparison test. A probability level of 0.05 or lesswasacceptedasindicatingastatisticallysignificantdifference (Tables1–4).

3. Results

CRF decreased significantly the number of entries (F(3,28)=5.489; p<0.001) and the time spent in interaction (F(3,28)=4.641; p<0.001) with the stranger female, but not that with thepartner female (F(3,28)=0.03286; p=0.9918 and

Table1

TheeffectsofCRF,antalarminandastressin2Bonthepreferenceforsocialnovelty ofmice.

Numberofentries

ANOVAtable SS DF MS F(DFn,DFd) pvalue

Interaction 92.05 6 15.34 F(6,108):3.582 p=0.0028 Novelty 182.2 2 91.08 F(2,108):21.27 p<0.0001 Treatment 175.4 3 58.48 F(3,108):13.65 p<0.0001

Residual 462.5 108 4.282

Timeofinteraction

ANOVAtable SS DF MS F(DFn,DFd) pvalue

Interaction 61947 6 10325 F(6,108):2.711 p=0.0172 Novelty 189754 2 94877 F(2,108):24.91 p<0.0001 Treatment 134586 3 44862 F(3,108):11.78 p<0.0001

Residual 411337 108 3809

Abbreviations:SSsumofsquares;DFtotaldegreesoffreedom;MSmeansquare;F (DFnDFd)Fdistribution(degreesoffreedomnumeratordegreesoffreedomdenom- inator);Pvalueprobabilityvalue.

Summaryofthestatisticaldatafromthesocialinteractiontest(two-wayANOVA withfactorA=noveltyandfactorB=treatmentwasperformed).

Table2

TheeffectsofCRF,CRFwithantalarminandCRFwithastressin2Bonthepreference forsocialnoveltyofmice.

Numberofentries

ANOVAtable SS DF MS F(DFn,DFd) pvalue

Interaction 58.89 6 9.816 F(6,84)=3.905 p=0.0017

Novelty 50.29 2 25.14 F(2,84):10 p=0.0001

Treatment 98.72 3 32.91 F(3,84):13.09 p<0.0001

Residual 211.1 84 2.513

Timeofinteraction

ANOVAtable SS DF MS F(DFn,DFd) pvalue

Interaction 43738 6 7290 F(6,84)=1.915 p=0.0877 Novelty 117742 2 58871 F(2,84):15.47 p<0.0001 Treatment 123125 3 41402 F(3,84):10.78 p<0.0001

Residual 319728 84 3806

Abbreviations:SSsumofsquares;DFtotaldegreesoffreedom;MSmeansquare;F (DFnDFd)Fdistribution(degreesoffreedomnumeratordegreesoffreedomdenom- inator);Pvalueprobabilityvalue.

Summaryofthestatisticaldatafromthesocialinteractiontest(two-wayANOVA withfactorA=noveltyandfactorB=treatmentwasperformed).

Table3

TheeffectsofUCN1,UCN2andUCN3onthepreferenceforsocialnoveltyofmice.

Numberofentries

ANOVAtable SS DF MS F(DFn,DFd) pvalue

Interaction 18.2 6 3.034 F(6,105):0.789 p=0.5801 Novelty 235.9 2 118 F(2,105):30.7 p<0.0001 Treatment 129.8 3 43.28 F(3,105):11.26 p<0.0001

Residual 403.4 105 3.842

Timeofinteraction

ANOVAtable SS DF MS F(DFn,DFd) pvalue

Interaction 2509 6 418.2 F(6,105):0.1446 p=0.9897 Novelty 268522 2 134261 F(2,105):46.43 p<0.0001 Treatment 4298 3 1433 F(3,105):0.495 p<0.6862

Residual 303621 105 2892

Abbreviations:SSsumofsquares;DFtotaldegreesoffreedom;MSmeansquare;F (DFnDFd)Fdistribution(degreesoffreedomnumeratordegreesoffreedomdenom- inator);Pvalueprobabilityvalue.

Summaryofthestatisticaldatafromthesocialinteractiontest(two-wayANOVA withfactorA=noveltyandfactorB=treatmentwasperformed).

(4)

0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

into the partner's area into the stranger's area total entries

nu m ber of en tr ie s

control (10) CRF (10) antalarmin (10) astressin 2B (10)

*

*

0 50 100 150 200 250 300

with the partner with the stranger total time

tim e s pe nt (s )

control (10) CRF (10) antalarmin (10) astressin 2B (10)

*

*

Fig.1.TheeffectsofCRF,antalarminandastressin2Bonthepreferenceforsocialnoveltyofmice.Thenumberofanimalsusedineachgrouphasbeenindicatedinbrackets.

Valuesarepresentedasmeans±SEM;statisticallysignificantdifferencewasacceptedforp<0.05andindicatedwith*forCRForantalarminvs.control.

Table4

TheeffectsofUCN1,UCN1withantalarminandUCN1withastressin2Bonthe preferenceforsocialnoveltyofmice.

Numberofentries

ANOVAtable SS DF MS F(DFn,DFd) pvalue

Interaction 22.99 6 3.832 F(6,84):1.965 p=0.0799 Novelty 157.1 2 78.54 F(2,84):40.26 p<0.0001 Treatment 156.5 3 52.17 F(3,84):26.74 p<0.0001

Residual 163.9 84 1.951

Table4(Continued) Timeofinteraction

ANOVAtable SS DF MS F(DFn,DFd) pvalue

Interaction 35465 6 5911 F(6,84):2.187 p:0.0521 Novelty 322153 2 161077 F(2,84):59.59 p<0.0001 Treatment 25498 3 8499 F(3,84):3.144 p=0.0294

Residual 227046 84 2703

Abbreviations:SSsumofsquares;DFtotaldegreesoffreedom;MSmeansquare;F (DFnDFd)Fdistribution(degreesoffreedomnumeratordegreesoffreedomdenom- inator);Pvalueprobabilityvalue.

Summaryofthestatisticaldatafromthesocialinteractiontest(two-wayANOVA withfactorA=noveltyandfactorB=treatmentwasperformed).

(5)

0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

into the partner's area into the stran ger's area total entries

nu m ber of en tr ie s

control (10) CRF (10) CRF + antalarmin (6) CRF + astressin 2B (6)

*

*

#

#

0 50 100 150 200 250 300

with the partner with the stranger total time

tim e s pe nt (s )

control (10) CRF (10) CRF + antalarmin (6) CRF + astressin 2B (6)

*

*

#

#

Fig.2. TheeffectsofCRF,CRFwithantalarminandCRFwithastressin2Bonthepreferenceforsocialnoveltyofmice.Thenumberofanimalsusedineachgrouphasbeen indicatedinbrackets.Valuesarepresentedasmeans±SEM;statisticallysignificantdifferencewasacceptedforp<0.05andindicatedwith*forCRFvs.controland#forCRF withantalarminvs.CRF.

F(3,28)=0.4039,p=0.7513),comparedtothecontrols(Fig.1).In addition,thetotalnumberofentries(F(3.28)=16.04;p<0.001)and thetotal timeof interaction(F(3.28)=8.259;p<0.05)decreased significantly(Fig.1).Antalarmin and astressin2Badministered alonewereineffective(p<0.05)(Fig.1).Thedecreasingeffectsof CRFwereblockedbyantalarmin(p<0.05),but notastressin2B (p<0.05)(Fig.2).

UCN1decreasedsignificantlythenumberofentriesintothe chamberoftheunknownfemale(F(3,35)=6.277;p<0.001), but notintothatwiththepartnerfemale(F(3,35)=1.614;p=0.2036),

withoutchanging thetimesof interactionspentwiththepart- ner female (F(3,35)=0.144; p=0.09328) or the strangerfemale (F(3,35)=0.2763; p=0.8421), compared to the control (Fig. 3).

Thetotalnumberofentries(F(3,35)=4.827;p<0.001)decreased significantly, in contrast with the total time of interaction (F(3,35)=0.5033;p=0.6825)thatwasnotinfluencedconsiderably byUCN1(Fig.3).UCN2andUCN3didnotinfluenceremarkably anyoftheparametersmeasured(p>0.05)(Fig.3).Thedecreasing effectsofUCN1werereversedbyantalarmin(p<0.05),butnot astressin2B(p>0.05)(Fig.4).

(6)

0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

into the partner's area into the strang er's area total entries

nu m ber of en tr ie s

control (10) urocortin 1 (10) urocortin 2 (10) urocortin 3 (9)

*

*

0 50 100 150 200 250 300

with the partner with the stranger total time

tim e s pe nt ( s)

control (10) urocortin 1 (10) urocortin 2 (10) urocortin 3 (9)

Fig.3. TheeffectsofUCN1,UCN2andUCN3onthepreferenceforsocialnoveltyofmice.Thenumberofanimalsusedineachgrouphasbeenindicatedinbrackets.Values arepresentedasmeans±SEM;statisticallysignificantdifferencewasacceptedforp<0.05andindicatedwith*forUCNvs.control.

4. Discussion

PreviousstudiesonthepossibleroleofCRFandCRF-relatedpep- tidesinsocialbehaviorofdifferentspecieshavebeenreviewedin tworecentstudies[25,26].Despitethattheprimaryfocusinthese studieshasbeenontheeffectsofsocialstressors,suchassocial defeatandsocialisolationontheCRFsystem[26],therehavebeen alsoinsightsontheroleofCRFsysteminprosocialandaffiliative behaviors,suchasparentalcare,maternaldefense,sexualbehav- iorandpairbonding [25].Theaimofthepresent studywasto investigatetheeffectsofthesepeptidesonthepreferenceforsocial noveltyfollowingpairbondformationinmice.

OurresultsdemonstratethatcentraladministrationofCRFand UCN1inducesadecreaseofthepreferenceforsocialnoveltyvia CRF1receptor,whichmayreflecttheanxiogenicactionoftheCRF1 receptor agonists[31,32].ButCRF1 receptoragonists mayexert theiranxiogenicactionthroughbothcentralandperipheraleffects [31,32].Thecentraleffectcanbemediatedbydifferentextrahy- pothalamicbrainregionsandneuronpopulationsinvolvedinstress reaction,suchasthebasolateralnucleusof theamygdala(BLA) [33].PreviousstudiesreferredthatinjectionofCRFandUCN1into theBLAreducedthetimesofsocialinteractioninmaleWistarrats andthatthiseffectwascompletelyabolishedbyadministrationof selectiveCRF1andnon-selectiveCRFreceptorantagonists[34–36].

(7)

0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

into the partner's area into the stranger's area total entries

number of entries

control (10) urocortin 1 (10) urocortin 1 +antalarmin (6) urocortin 1 + astressin 2B (6)

*

*

#

#

0 50 100 150 200 250 300

with the partner with the stranger total time

time spent (s)

control (10) urocortin 1 (10) urocortin 1 + antalarmin (6) urocortin 1 + astressin 2B (6)

Fig.4.TheeffectsofUCN1,UCN1withantalarminandUCN1withastressin2Bonthepreferenceforsocialnoveltyofmice.Thenumberofanimalsusedineachgrouphas beenindicatedinbrackets.Valuesarepresentedasmeans±SEM;statisticallysignificantdifferencewasacceptedforp<0.05andindicatedwith*forUCN1vs.controland

#forUCN1withantalarminvs.UCN1.

UCN1provedevenmorepotentthanCRFinreducingthetimeof interaction,whichisconsistentwithitshigheraffinityfortheCRF1 receptor[34–36].TheperipheraleffectoftheCRF1 agonistscan bemediatedbyactivationoftheHPAaxis.Actually,ICVinjection ofthesamedose(5␮g/2␮l)ofCRForUCNIthatwasusedinthe presentexperimentsledtoelevationofplasmaACTHandcorticos- teroneconcentrationswithin30mininourpreviousexperiments [15].ThereforetheimpactoftheHPAaxisactivationonthebehav- iorofthemiceobservedinthethree-chambersocialinteraction testcannotbeexcluded.Inaddition,a previousstudyusingICV injectionofCRFinmaleListerrats,suggestedthattheanxiogenic effectofCRFobservedinaclassicalsocialinteractiontest[31],can becausedbythereleaseofpituitaryACTH,sincethishormonealso decreasedsocialinteractionwithoutreducinglocomotoractivity [31,32],butisunlikelytobeduebythereleaseofadrenalcorticos-

terone,sincethishormonedidnotdecreasesocialinteraction,and insomedosesincreasedit[31,32].

Our resultsalso demonstrate that central administration of UCN2and UCN3doesnotalter thepreference forsocial nov- elty,andgenerallythesocialinteractionofmalemicewithfemale mice.However,previousstudiesclaimedthatmale,butnotfemale, UCN2knock-outmiceexhibitedmorepassivesocialinteractions and reduced aggressivenesstonovel conspecifics[22] and that bothmaleandfemaleUCN3andCRF2receptorknock-outmice expressedanenhancedsocialmemoryandincreasedpreference forsocialnovelty,whencomparedtowild-typemice[23].These studiessuggestthatCRF2agonistswouldmodulatesomeaspects ofsocialbehavior.Incontrast,amorerecentstudystatedthatmice deficientinUCN3orCRF2 receptor localizedspecificallyinthe medialnucleusoftheamygdala(MEA)showeddecreasedprefer- enceforsocialnovelty[37].Moreover,pharmacologicalactivation

(8)

oftheCRF2receptorsoroptogeneticactivationofUCN3neurons intheMEAprovedtheopposite,anincreasedpreferenceforsocial noveltyofmice.ThisstudysuggeststhatUCN3fromtheMEAwould modulatetheabilityofmicetocopewithsocialchallengesviaCRF2 receptors[37].

Ourexperimentswereoriginallyinspiredbythreestudiesusing fourdifferentvolespecies (prairie,pine,montane and meadow voles),which,based ontheircloserelationship,butremarkably differentsocialbehavior(prairieandpinevolesaremonogamous, whilemontaneandmeadowvolesarepromiscuous),areconsid- eredemergingmodelorganismsforunderstandingthesocialbrain [38].Inthefirststudyusingreceptorautoradiography,amarked differencein thebrain distributionof CRF1 and CRF2 receptors between monogamous and promiscuous species (e.g., a higher expressionofCRF2receptorandalowerexpressionofCRF1recep- torinthenucleusaccumbens(NACC)oftheprairieandpinevoles), andmaleandfemalesex(e.g.,higherlevelsofCRF2receptorbind- ingintheencapsulatedbednucleusofstriaterminalis(BNST)in malevoles)wasdemonstrated.Inthesecondstudyusinginsitu hybridizationandimmunocytochemistry,nodifferencebetween thebrain distribution of CRF (the NACC, the BNST, thecentral nucleusoftheamygdalaetc.)andUCN1(theEdinger-Westphal nucleus)wasdemonstratedbetweenmonogamousandpromiscu- ousvoles[39].Inthethirdstudy,microinjectionofCRFandUCN1 intotheNACCinducedanaccelerationofthepartnerpreferencefor- mationinmonogamousprairievoles,butnotinnon-monogamous meadowvoles,thatwaseffectivelyblockedbyintraaccumbalinjec- tionofbothselectiveCRF1andselectiveCRF2receptorantagonists [40].Takingintoconsiderationthaturocortinergicfiberswerenot presentintheNACC,thisstudysuggeststhatthereleaseofCRFin theNACCfacilitatespartnerpreferenceinthemonogamousspecies activatingbothCRFreceptors[40].Thelackofthisfacilitationeffect inthenon-monogamousspeciescanbeexplainedbythelackof thecorrespondentreceptorsintheirbrain,despiteofthesimilar distributionoftheirligands[39,41].

Inconclusion,thepresentstudysuggeststhatCRFandUCN1 decreasethepreferenceforsocialnoveltybyactivatingCRF1recep- tors,whileUCN2andUCN3,activatingselectivelyCRF2receptors, donotparticipatetomale-femaleinteractioninthepromiscuous CFLPmice.Thisconclusioncanbeunderlinedbythehigherexpres- sionofCRF1 receptorsandlowerexpressionofCRF2receptorsin thebrainsofnon-monogamousspecieswhichhavebeenpreviously demonstrated.

Acknowledgements

ThisstudywassupportedbytheNeuroscienceResearchGroup oftheHungarianAcademyof SciencesandtheHungarianBrain ResearchProgram.

References

[1]W.Vale,J.Spiess,C.Rivier,J.Rivier,Characterizationofa41-residueovine hypothalamicpeptidethatstimulatessecretionofcorticotropinand beta-endorphin,Science213(1981)1394–1397.

[2]C.Tsigos,G.P.Chrousos,Hypothalamic-pituitary-adrenalaxis,

neuroendocrinefactorsandstress,J.Psychosom.Res.53(2002)865–871.

[3]G.A.Carrasco,L.D.VandeKar,Neuroendocrinepharmacologyofstress,Eur.J.

Pharmacol.463(2003)235–272.

[4]J.Vaughan,C.Donaldson,J.Bittencourt,M.H.Perrin,K.Lewis,S.Sutton,etal., Urocortin,amammalianneuropeptiderelatedtofishurotensinIandto corticotropin-releasingfactor,Nature378(1995)287–292.

[5]T.M.Reyes,K.Lewis,M.H.Perrin,K.S.Kunitake,J.Vaughan,C.A.Arias,etal., UrocortinII:amemberofthecorticotropin-releasingfactor(CRF) neuropeptidefamilythatisselectivelyboundbytype2CRFreceptors,Proc.

Natl.Acad.Sci.U.S.A.98(2001)2843–2848.

[6]K.Lewis,C.Li,M.H.Perrin,A.Blount,K.Kunitake,C.Donaldson,etal., IdentificationofurocortinIII,anadditionalmemberofthe

corticotropin-releasingfactor(CRF)familywithhighaffinityfortheCRF2 receptor,Proc.Natl.Acad.Sci.U.S.A.98(2001)7570–7575.

[7]C.P.Chang,R.V.Pearse,2nd,O’ConnellS,RosenfeldMG.Identificationofa seventransmembranehelixreceptorforcorticotropin-releasingfactorand sauvagineinmammalianbrain,Neuron11(1993)1187–1195.

[8]D.P.Behan,E.B.DeSouza,P.J.Lowry,E.Potter,P.Sawchenko,W.W.Vale, Corticotropinreleasingfactor(CRF)bindingprotein:anovelregulatorofCRF andrelatedpeptides,Front.Neuroendocrinol.16(1995)362–382.

[9]K.H.Skelton,M.J.Owens,C.B.Nemeroff,Theneurobiologyofurocortin,Regul.

Pept.93(2000)85–92.

[10]E.M.Fekete,E.P.Zorrilla,Physiology,pharmacology,andtherapeutic relevanceofurocortinsinmammals:ancientCRFparalogs,Front.

Neuroendocrinol.28(2007)1–27.

[11]D.K.Grammatopoulos,H.S.Randeva,M.A.Levine,K.A.Kanellopoulou,E.W.

Hillhouse,Ratcerebralcortexcorticotropin-releasinghormonereceptors:

evidenceforreceptorcouplingtomultipleG-proteins,J.Neurochem.76 (2001)509–519.

[12]F.M.Dautzenberg,R.L.Hauger,C.R.F.The,peptidefamilyandtheirreceptors:

yetmorepartnersdiscovered,TrendsPharmacol.Sci.23(2002)71–77.

[13]J.M.Reul,F.Holsboer,Corticotropin-releasingfactorreceptors1and2in anxietyanddepression,Curr.Opin.Pharmacol.2(2002)23–33.

[14]K.VanPett,V.Viau,J.C.Bittencourt,R.K.Chan,H.Y.Li,C.Arias,etal., DistributionofmRNAsencodingCRFreceptorsinbrainandpituitaryofrat andmouse,J.Comp.Neurol.428(2000)191–212.

[15]Z.Bagosi,K.Csabafi,M.Palotai,M.Jaszberenyi,I.Foldesi,J.Gardi,etal.,The effectofurocortinIonthehypothalamicACTHsecretagoguesanditsimpact onthehypothalamic-pituitary-adrenalaxis,Neuropeptides48(2014)15–20.

[16]T.Suda,K.Kageyama,S.Sakihara,T.Nigawara,Physiologicalrolesof urocortins,humanhomologuesoffishurotensinI,andtheirreceptors, Peptides25(2004)1689–1701.

[17]Z.Bagosi,K.Csabafi,M.Jaszberenyi,G.Telegdy,Theeffectsof corticotropin-releasingfactorandtheurocortinsonhypothalamic gamma-aminobutyricacidrelease–theimpactsonthe

hypothalamic-pituitary-adrenalaxis,Neurochem.Int.60(2012)350–354.

[18]Z.Bagosi,K.Csabafi,M.Palotai,M.Jaszberenyi,I.Foldesi,J.Gardi,etal.,The interactionofUrocortinIIandUrocortinIIIwithamygdalarandhypothalamic cotricotropin-releasingfactor(CRF)–reflectionsontheregulationofthe hypothalamic-pituitary-adrenal(HPA)axis,Neuropeptides47(2013) 333–338.

[19]D.Richard,Q.Lin,E.Timofeeva,Thecorticotropin-releasingfactorfamilyof peptidesandCRFreceptors:theirrolesintheregulationofenergybalance, Eur.J.Pharmacol.440(2002)189–197.

[20]V.Martinez,L.Wang,J.E.Rivier,W.Vale,Y.Tache,Differentialactionsof peripheralcorticotropin-releasingfactor(CRF),urocortinII,andurocortinIII ongastricemptyingandcolonictransitinmice:roleofCRFreceptorsubtypes 1and2,J.Pharmacol.Exp.Ther.301(2002)611–617.

[21]K.Takahashi,K.Totsune,O.Murakami,S.Shibahara,Urocortinsas cardiovascularpeptides,Peptides25(2004)1723–1731.

[22]J.Breu,C.Touma,S.M.Holter,A.Knapman,W.Wurst,J.M.Deussing,Urocortin 2modulatesaspectsofsocialbehaviourinmice,Behav.BrainRes.233(2012) 331–336.

[23]J.M.Deussing,J.Breu,C.Kuhne,M.Kallnik,M.Bunck,L.Glasl,etal.,Urocortin 3modulatessocialdiscriminationabilitiesviacorticotropin-releasing hormonereceptortype2,J.Neurosci.30(2010)9103–9116.

[24]D.R.Gehlert,A.Shekhar,S.M.Morin,P.A.Hipskind,C.Zink,S.L.Gackenheimer, etal.,StressandcentralUrocortinincreaseanxiety-likebehaviorinthesocial interactiontestviatheCRF1receptor,Eur.J.Pharmacol.509(2005)145–153.

[25]C.M.Hostetler,A.E.Ryabinin,C.R.F.The,systemandsocialbehavior:areview, Front.Neurosci.7(2013)92.

[26]T.Backstrom,S.Winberg,Centralcorticotropinreleasingfactorandsocial stress,Front.Neurosci.7(2013)117.

[27]B.L.Pearson,E.B.Defensor,D.C.Blanchard,R.J.Blanchard,C57BL/6Jmicefailto exhibitpreferenceforsocialnoveltyinthethree-chamberapparatus,Behav.

BrainRes.213(2010)189–194.

[28]G.Paxinos,K.B.J.Franklin,TheMouseBraininStereotaxicCoordinates.

Compact,2nded.,ElsevierAcademicPress,Amsterdam;Boston,2004.

[29]J.N.Crawley,What’sWrongwithMyMouse?:BehavioralPhenotypingof TransgenicandKnockoutMice,2nded.,Wiley-Interscience,N.J.Hoboken, 2007.

[30]O.Kaidanovich-Beilin,T.Lipina,I.Vukobradovic,J.Roder,J.R.Woodgett, Assessmentofsocialinteractionbehaviors,J.Vis.Exp.(2011).

[31]A.J.Dunn,S.E.File,Corticotropin-releasingfactorhasananxiogenicactionin thesocialinteractiontest,Horm.Behav.21(1987)193–202.

[32]S.E.File,P.Seth,Areviewof25yearsofthesocialinteractiontest,Eur.J.

Pharmacol.463(2003)35–53.

[33]D.Janssen,T.Kozicz,Isitreallyamatterofsimpledualism?

Corticotropin-releasingfactorreceptorsinbodyandmentalhealth,Front Endocrinol(Lausanne)4(2013)28.

[34]T.J.Sajdyk,D.A.Schober,D.R.Gehlert,A.Shekhar,Roleof

corticotropin-releasingfactorandurocortinwithinthebasolateralamygdala ofratsinanxietyandpanicresponses,Behav.BrainRes.100(1999)207–215.

[35]B.M.Campbell,J.L.Morrison,E.L.Walker,K.M.Merchant,Differential regulationofbehavioral,genomic,andneuroendocrineresponsesbyCRF infusionsinrats,Pharmacol.Biochem.Behav.77(2004)447–455.

[36]F.Spiga,S.L.Lightman,A.Shekhar,C.A.Lowry,Injectionsofurocortin1into thebasolateralamygdalainduceanxiety-likebehaviorandc-Fosexpression inbrainstemserotonergicneurons,Neuroscience138(2006)1265–1276.

(9)

[37]Y.Shemesh,O.Forkosh,M.Mahn,S.Anpilov,Y.Sztainberg,S.Manashirov, etal.,Ucn3andCRF-R2inthemedialamygdalaregulatecomplexsocial dynamics,Nat.Neurosci.19(2016)1489–1496.

[38]L.A.McGraw,L.J.Young,Theprairievole:anemergingmodelorganismfor understandingthesocialbrain,TrendsNeurosci.33(2010)103–109.

[39]M.M.Lim,N.O.Tsivkovskaia,Y.Bai,L.J.Young,A.E.Ryabinin,Distributionof corticotropin-releasingfactorandurocortin1inthevolebrain,BrainBehav.

Evol.68(2006)229–240.

[40]M.M.Lim,Y.Liu,A.E.Ryabinin,Y.Bai,Z.Wang,L.J.Young,CRFreceptorsinthe nucleusaccumbensmodulatepartnerpreferenceinprairievoles,Horm.

Behav.51(2007)508–515.

[41]M.M.Lim,H.P.Nair,L.J.Young,Speciesandsexdifferencesinbrain distributionofcorticotropin-releasingfactorreceptorsubtypes1and2in monogamousandpromiscuousvolespecies,J.Comp.Neurol.487(2005) 75–92.

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

Since unlike in female mice, in RTX-pretreated males we could not detect a significantly increased pathological bone formation as compared to the non-pretreated animals, it can

When we examined the oral samples we could observe that the female partners of those male patients who had genital HPV infection had a higher rate of oral HPV

The aim of this work was to analyze mobbing in terms of characteristics of mobbing behaviors for male and female victims, the actors involved, the workplace, the motives,

Major research areas of the Faculty include museums as new places for adult learning, development of the profession of adult educators, second chance schooling, guidance

The decision on which direction to take lies entirely on the researcher, though it may be strongly influenced by the other components of the research project, such as the

ered by the male-specific surface component(s) , 9 2 Another adsorbs equally well to male and female cells of S. The same conclusion is suggested by the low fertility of

H Stage larva invades root and causes formation of syncytio Ì Stage male and female larvae feeding on syncytia &#34;ΠΣ Stage larvae ^Syncytia of male pegins to degenerate

What on an archetypal level may seem to be an &#34;unending struggle for power between male and female&#34; (Holmberg 95), from the perspective of carnivalization, the